Inter-Observer Agreement in Assessment of Response to Neo-Adjuvant Chemotherapy in Tubo-Ovarian High-Grade Serous Carcinoma

被引：0
|
作者：
Singh, Naveena
Said, Ian
Faruqi, Asma Z.
Leen, Sarah L.
Trevisan, Giorgia
Hirschowitz, Lynn
Ganesan, Raji
Vella, Jo
McCluggage, Glenn
Gilks, Blake
Boehm, Steffen
机构：
[1] Barts Hlth NHS Trust, London, England
[2] Univ Coll London Hosp, London, England
[3] Birmingham Womens Hosp, Birmingham, W Midlands, England
[4] Royal Victoria Hosp, Belfast BT12 6BA, Antrim, North Ireland
[5] Vancouver Gen Hosp, Vancouver, BC, Canada
来源：
LABORATORY INVESTIGATION | 2016年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1229
引用
收藏
页码：309A / 310A
页数：2
相关论文
共 50 条
  • [21] PATIENTS RECEIVING NEOADJUVANT CHEMOTHERAPY FOR HIGH-GRADE SEROUS TUBO-OVARIAN CARCINOMA; DOES RADIOLOGICAL RESPONSE CORRELATE WITH THE CRS IN DETERMINING PROGNOSIS?
    McNulty, M.
    Dean, A.
    Cohen, P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 769 - 769
  • [22] Tertiary lymphoid structures in high-grade serous tubo-ovarian carcinoma: anatomical site matters
    Westbom-Fremer, Sofia
    Tran, Lena
    Ebbesson, Anna
    de la Fuente, Laura Martin
    Jonsson, Jenny-Maria
    Kannisto, Paivi
    Veerla, Srinivas
    Hedenfalk, Ingrid
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2025, 74 (02)
  • [23] Chemotherapy Response Score: Validation of a 3-Tier Histopathological Scoring System for Assessing Response To Neoadjuvant Chemotherapy in High-Grade Serous Tubo-Ovarian Carcinoma
    Singh, Naveena
    Gilks, C. Blake
    Faruqi, Asma
    Said, Ian
    Tinker, Anna
    Le, Nhu
    Boehm, Steffen
    LABORATORY INVESTIGATION, 2015, 95 : 308A - 308A
  • [24] Chemotherapy Response Score: Validation of a 3-Tier Histopathological Scoring System for Assessing Response To Neoadjuvant Chemotherapy in High-Grade Serous Tubo-Ovarian Carcinoma
    Singh, Naveena
    Gilks, C. Blake
    Faruqi, Asma
    Said, Ian
    Tinker, Anna
    Le, Nhu
    Boehm, Steffen
    MODERN PATHOLOGY, 2015, 28 : 308A - 308A
  • [25] SPL-108 mediates metastasis and chemoresistance in high-grade serous tubo-ovarian carcinoma
    Lara, Olivia
    Pereira, Luiza Doro
    Van Oudenhove, Elke
    Olvera, Narciso
    Dao, Fanny
    Hacker, Kari
    Levine, Douglas
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S276 - S276
  • [26] Prognostic Role of Histological Tumor Regression in Patients Receiving Neoadjuvant Chemotherapy for High-Grade Serous Tubo-ovarian Carcinoma
    Coghlan, Edwina
    Meniawy, Tarek M.
    Munro, Aime
    Bulsara, Max
    Stewart, Colin J. R.
    Tan, Adeline
    Koay, M. H. Eleanor
    MaGee, Daniel
    Codde, Jim
    Tan, Jason
    Salfinger, Stuart G.
    Mohan, Ganendra R.
    Leung, Yee
    Nichols, Cassandra B.
    Cohen, Paul A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (04) : 708 - 713
  • [27] LRP1B-a prognostic marker in tubo-ovarian high-grade serous carcinoma
    Kolb, Svenja
    Hoffmann, Inga
    Monje, Nanna
    Dragomir, Mihnea P.
    Jank, Paul
    Bischoff, Philip
    Keunecke, Carlotta
    Pohl, Jonathan
    Kunze, Catarina Alisa
    Marchenko, Sofya
    Schmitt, Wolfgang D.
    Kulbe, Hagen
    Sers, Christine
    Sehouli, Jalid
    Braicu, Elena Ioana
    Denkert, Carsten
    Darb-Esfahani, Silvia
    Horst, David
    Sinn, Bruno V.
    Taube, Eliane T.
    HUMAN PATHOLOGY, 2023, 141 : 158 - 168
  • [28] Improvement of radiological disease on CT after neoadjuvant chemotherapy may not correlate with chemotherapy response score (CRS) in advanced tubo-ovarian high-grade serous ovarian carcinoma
    Sugrue, R.
    James, K.
    Growdon, W. B.
    Clark, R. M.
    del Carmen, M. G.
    Melamed, A.
    Bregar, A. J.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 110 - 111
  • [29] Should All Cases of High-Grade Serous Ovarian, Tubal, and Primary Peritoneal Carcinomas Be Reclassified as Tubo-Ovarian Serous Carcinoma?
    Moss, Esther Louise
    Evans, Tim
    Pearmain, Philippa
    Askew, Sarah
    Singh, Kavita
    Chan, Kiong K.
    Ganesan, Raji
    Hirschowitz, Lynn
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (07) : 1201 - 1207
  • [30] TP53-wildtype High-Grade Serous Tubo-Ovarian Carcinomas
    Chui, M. Herman
    Soslow, Robert
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1029 - 1029
12345